Welcome to the forefront of innovation in clinical trials! Our dedicated space for TRI's Risk-Based Quality Management insights is where cutting-edge practices meet practical guidance. Dive into our expertly curated blog, your go-to resource for the latest in RBQM methodologies, training opportunities, and thought leadership.
Welcome to the March edition of The Quality Issue, where we zero in on the latest in Good Clinical Practice (GCP) and RBQM news. Before we dive in, we’d like to extend a heartfelt thank you to everyone who has subscribed to our newsletter. Your engagement has been instrumental in shaping the content and direction […]
This issue starts on a note of appreciation: We celebrate Dr. Janet Woodcock’s remarkable legacy as she retires from the FDA, a journey that began in 1986. Dr. Woodcock’s pioneering introduction of risk management redefined drug safety, emphasizing a balance between benefits and risks. Her leadership has modernized drug approval and safety standards, notably through […]
We’re kicking off 2024 by welcoming you to our revamped e-newsletter, “The Quality Issue”. Delivered monthly, the quality issue will feature exciting updates on what team TRI is working on for you, industry news, and helpful insights from RBQM Subject Matter Experts. Let’s dive in! Upcoming Events Join the Excitement at the 4th Annual #RBQMSummit […]
RESEARCH TRIANGLE PARK, NC– June 22, 2021 – Worldwide Clinical Trials, Inc., (Worldwide) the industry’s leading global, midsized, full-service contract research organization (CRO), and Triumph Research Intelligence (TRI), a global leader in risk-based quality management (RBQM) technology, announced they are teaming up to optimize quality for clinical trials globally. A market need further accelerated by the […]
